An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence

In bioequivalence, the maximum plasma concentration (Cmax) is traditionally used as a metric for the absorption rate, despite the fact that there are several concerns. The idea of “average slope” (AS) was recently introduced as an alternative metric to reflect absorption rate. This study aims to fur...

Full description

Bibliographic Details
Main Author: Vangelis D. Karalis
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/5/725
_version_ 1797598652736208896
author Vangelis D. Karalis
author_facet Vangelis D. Karalis
author_sort Vangelis D. Karalis
collection DOAJ
description In bioequivalence, the maximum plasma concentration (Cmax) is traditionally used as a metric for the absorption rate, despite the fact that there are several concerns. The idea of “average slope” (AS) was recently introduced as an alternative metric to reflect absorption rate. This study aims to further extend the previous findings and apply an in silico approach to investigate the kinetic sensitivity of AS and Cmax. This computational analysis was applied to the C-t data of hydrochlorothiazide, donepezil, and amlodipine, which exhibit different absorption kinetics. Principal component analysis (PCA) was applied to uncover the relationships between all bioequivalence metrics. Monte Carlo simulations of bioequivalence trials were performed to investigate sensitivity. The appropriate programming codes were written in Python for the PCA and in MATLAB<sup>®</sup> for the simulations. The PCA verified the desired properties of AS and the unsuitability of Cmax to reflect absorption rate. The Monte Carlo simulations showed that AS is quite sensitive to detecting differences in absorption rate, while Cmax has almost negligible sensitivity. Cmax fails to reflect absorption rate, and its use in bioequivalence gives only a false impression. AS has the appropriate units, is easily calculated, exhibits high sensitivity, and has the desired properties of absorption rate.
first_indexed 2024-03-11T03:25:12Z
format Article
id doaj.art-2cd8fac3328f4485822e2ade23c3ebcd
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-11T03:25:12Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-2cd8fac3328f4485822e2ade23c3ebcd2023-11-18T02:49:01ZengMDPI AGPharmaceuticals1424-82472023-05-0116572510.3390/ph16050725An In Silico Approach toward the Appropriate Absorption Rate Metric in BioequivalenceVangelis D. Karalis0Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15784 Athens, GreeceIn bioequivalence, the maximum plasma concentration (Cmax) is traditionally used as a metric for the absorption rate, despite the fact that there are several concerns. The idea of “average slope” (AS) was recently introduced as an alternative metric to reflect absorption rate. This study aims to further extend the previous findings and apply an in silico approach to investigate the kinetic sensitivity of AS and Cmax. This computational analysis was applied to the C-t data of hydrochlorothiazide, donepezil, and amlodipine, which exhibit different absorption kinetics. Principal component analysis (PCA) was applied to uncover the relationships between all bioequivalence metrics. Monte Carlo simulations of bioequivalence trials were performed to investigate sensitivity. The appropriate programming codes were written in Python for the PCA and in MATLAB<sup>®</sup> for the simulations. The PCA verified the desired properties of AS and the unsuitability of Cmax to reflect absorption rate. The Monte Carlo simulations showed that AS is quite sensitive to detecting differences in absorption rate, while Cmax has almost negligible sensitivity. Cmax fails to reflect absorption rate, and its use in bioequivalence gives only a false impression. AS has the appropriate units, is easily calculated, exhibits high sensitivity, and has the desired properties of absorption rate.https://www.mdpi.com/1424-8247/16/5/725in silico methodsbioequivalencepharmacokineticsabsorption ratemachine learningMonte Carlo simulations
spellingShingle Vangelis D. Karalis
An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence
Pharmaceuticals
in silico methods
bioequivalence
pharmacokinetics
absorption rate
machine learning
Monte Carlo simulations
title An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence
title_full An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence
title_fullStr An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence
title_full_unstemmed An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence
title_short An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence
title_sort in silico approach toward the appropriate absorption rate metric in bioequivalence
topic in silico methods
bioequivalence
pharmacokinetics
absorption rate
machine learning
Monte Carlo simulations
url https://www.mdpi.com/1424-8247/16/5/725
work_keys_str_mv AT vangelisdkaralis aninsilicoapproachtowardtheappropriateabsorptionratemetricinbioequivalence
AT vangelisdkaralis insilicoapproachtowardtheappropriateabsorptionratemetricinbioequivalence